EUVIMEDEUVIMED entdecken
Crossref

HOXA1 Promotes Migration, Invasion and Cell Cycle, and Suppresses Cisplatin Sensitivity of Laryngeal Cancer Cells By Mediating AKT/mTOR Pathway

Shaohao Luo, Yunfei Bai, Boqian Wang, Haixia Xu, Shu Zhang, Gang Guo, Xin Li, Hongyang Sun, Xiaobo Cui

The Tohoku Journal of Experimental Medicine · 2025

DOI: 10.1620/tjem.2024.j073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Tohoku Journal of Experimental Medicine, 2025. Verfasst von Shaohao Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Inner Mongolia Medical University. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, Cell Movement, Cisplatin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Homeobox A1 (HOXA1) is implicated in the progression of various cancers, but its biological function in laryngeal cancer (LC) remains undefined, which is the foothold of our study. Bioinformatics analysis and survival analysis were performed to predict HOXA1 expression in LC tissues, and the prognostic relationship between high HOXA1 expression and LC. Whether high HOXA1 expression correlated with the clinical characteristics and prognosis of LC patients was analyzed. LC cell viability and sensitivity to cisplatin were determined by Methyl thiazolyl tetrazolium assay. The cell migration, invasion, and cell cycle after transfection were examined by Wound healing, Transwell, and flow cytometry assays, respectively. The corresponding mRNA and protein expressions were measured by quantitative real-time PCR or Western blot. A higher expression of HOXA1 was detected in LC tissues, which was found to be relevant to poor prognosis of LC patients. The association of high expression of HOXA1 with lymph node and clinical stage was also confirmed. Silencing of HOXA1 in LC cells enhanced the cell sensitivity to cisplatin, inhibited viability, migration, invasion and cell cycle, and reduced N-Cadherin, Vimentin, PCNA, p-AKT and p-mTOR expressions, while overexpression of HOXA1 had the opposite effects. Collectively, HOXA1 boosts migration, invasion and cell cycle, while suppressing cisplatin sensitivity of LC cells by mediating AKT/mTOR pathway, hinting that HOXA1 is a promising biomarker for diagnosis and prognosis of LC in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktCell MovementCisplatinHomeodomain ProteinsLaryngeal NeoplasmsSignal TransductionCell CycleTranscription FactorsHumansNeoplasm InvasivenessCell Line, TumorMaleFemaleGene Expression Regulation, NeoplasticMiddle AgedPrognosisCell SurvivalHomeobox A1 Protein

Stichwörter der Autor:innen

AKT/mTOR pathwayhomeobox A1invasionlaryngeal cancermigration

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktCisplatinHomeodomain ProteinsTranscription FactorsHomeobox A1 ProteinMTOR protein, human

Autor:innen und Institutionen

  • Graduate School, Inner Mongolia Medical University.
  • Department of Otolaryngology, Head and Neck Surgery, the Affiliated Hospital of Inner Mongolia Medical University.

Zitieren

APA

Luo, S., Bai, Y., Wang, B., Xu, H., Zhang, S., Guo, G., Li, X., Sun, H., & Cui, X. (2025). HOXA1 Promotes Migration, Invasion and Cell Cycle, and Suppresses Cisplatin Sensitivity of Laryngeal Cancer Cells By Mediating AKT/mTOR Pathway. The Tohoku Journal of Experimental Medicine. https://doi.org/10.1620/tjem.2024.j073

Vancouver

Luo S, Bai Y, Wang B, Xu H, Zhang S, Guo G, et al. HOXA1 Promotes Migration, Invasion and Cell Cycle, and Suppresses Cisplatin Sensitivity of Laryngeal Cancer Cells By Mediating AKT/mTOR Pathway. The Tohoku Journal of Experimental Medicine. 2025. doi:10.1620/tjem.2024.j073

BibTeX
@article{Luo2025,
  author = {Luo, Shaohao and Bai, Yunfei and Wang, Boqian and Xu, Haixia and Zhang, Shu and Guo, Gang and Li, Xin and Sun, Hongyang and Cui, Xiaobo},
  title = {HOXA1 Promotes Migration, Invasion and Cell Cycle, and Suppresses Cisplatin Sensitivity of Laryngeal Cancer Cells By Mediating AKT/mTOR Pathway},
  journal = {The Tohoku Journal of Experimental Medicine},
  year = {2025},
  doi = {10.1620/tjem.2024.j073}
}
Kostenlos starten →